StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) stock

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.42−0.15 (-2.69%)

Close on Nov 17, 2026Market cap $58.19MP/E –Yield –

PharmaCyte Biotech gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2013 it was 20.9%, against 70.9% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2013Apr 30, 201320.9%−50.0
FY2012Apr 30, 201270.9%−3.6
FY2011Apr 30, 201174.5%–

More PharmaCyte Biotech figures

See a number that looks wrong?